Abatacept in Immune Checkpoint Inhibitor Myocarditis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Abatacept in Immune Checkpoint Inhibitor Myocarditis	cancer, cardiomyopathy, cardiovascular disorder, heart disorder, myocarditis, neoplasm	Recruiting	Phase 3	2026-08-20		NCT05335928

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bristol-Myers Squibb	422
Massachusetts General Hospital	758

31 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Allegheny-Singer Research Institution	Pittsburgh	United States	1
Aurora St Luke's Medical Center	Milwaukee	United States	5
Beth Israel Deaconess Medical Center	Boston	United States	45
Boston Medical Center	Boston	United States	200
Brigham and Women's Hospital	Boston	United States	60
Cedars-Sinai Medical Center	Los Angeles	United States	1
Cleveland Clinic	Cleveland	United States	558
Columbia University Irving Medical Center	New York	United States	234
Franciscan Health	Indianapolis	United States	12
Johns Hopkins	Baltimore	United States	39
Lehigh Valley Health Network	Bethlehem	United States	1
Maine Health	Portland	United States	3
Massachusetts General Hospital	Boston	United States	1015
Mayo Clinic	Rochester	United States	664
McMaster University	Hamilton	Canada	1
MD Anderson Cancer Center	Houston	United States	589
MedStar Health Research Institute, Georgetown University	Washington D.C.	United States	1
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Moffitt Cancer Center	Tampa	United States	523
Robert Wood Johnson University Hospital	New Brunswick	United States	22
University of British Colombia	Vancouver	Canada	1
University of California Los Angeles	Los Angeles	United States	87
University of Chicago	Chicago	United States	312
University of Kansas Medical Center	Kansas City	United States	240
University of Kentucky	Lexington	United States	2

Clinical trials